Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Resistin in Human Seminal Plasma: Relationship with Lipid Peroxidation, CAT Activity, GSH/GSSG Ratio, and Semen Parameters.

Moretti E, Micheli L, Noto D, Fiaschi AI, Menchiari A, Cerretani D.

Oxid Med Cell Longev. 2019 Oct 22;2019:2192093. doi: 10.1155/2019/2192093. eCollection 2019.

2.

Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer.

Petrioli R, Francini E, Cherri S, Torre P, Fiaschi AI, Miano ST, Marrelli D, Rovello F, Francini G.

Clin Colorectal Cancer. 2018 Dec;17(4):e663-e669. doi: 10.1016/j.clcc.2018.07.002. Epub 2018 Jul 4.

PMID:
30153975
3.

Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy.

Petrioli R, Chirra M, Messuti L, Fiaschi AI, Savelli V, Martellucci I, Francini E.

Clin Colorectal Cancer. 2018 Dec;17(4):307-312. doi: 10.1016/j.clcc.2018.02.005. Epub 2018 Feb 21.

PMID:
29548772
4.

Diffuse Axonal Injury and Oxidative Stress: A Comprehensive Review.

Frati A, Cerretani D, Fiaschi AI, Frati P, Gatto V, La Russa R, Pesce A, Pinchi E, Santurro A, Fraschetti F, Fineschi V.

Int J Mol Sci. 2017 Dec 2;18(12). pii: E2600. doi: 10.3390/ijms18122600. Review.

5.

Nitric oxide, malondialdheyde and non-enzymatic antioxidants assessed in viable spermatozoa from selected infertile men.

Moretti E, Collodel G, Fiaschi AI, Micheli L, Iacoponi F, Cerretani D.

Reprod Biol. 2017 Dec;17(4):370-375. doi: 10.1016/j.repbio.2017.10.003. Epub 2017 Oct 18.

PMID:
29055788
6.

Biofortification with Iron and Zinc Improves Nutritional and Nutraceutical Properties of Common Wheat Flour and Bread.

Ciccolini V, Pellegrino E, Coccina A, Fiaschi AI, Cerretani D, Sgherri C, Quartacci MF, Ercoli L.

J Agric Food Chem. 2017 Jul 12;65(27):5443-5452. doi: 10.1021/acs.jafc.7b01176. Epub 2017 Jun 28.

PMID:
28656773
7.

Myocardial oxidative damage is induced by cardiac Fas-dependent and mitochondria-dependent apoptotic pathways in human cocaine-related overdose.

Turillazzi E, Cerretani D, Cantatore S, Fiaschi AI, Frati P, Micheli L, Neri M, Cipolloni L, Di Paolo M, Pinchi E, Riezzo I, Santurro A, Vullo A, Fineschi V.

Sci Rep. 2017 Mar 10;7:44262. doi: 10.1038/srep44262.

8.

Apatinib for the treatment of gastric cancer.

Roviello G, Ravelli A, Fiaschi AI, Cappelletti MR, Gobbi A, Senti C, Zanotti L, Polom K, Reynolds AR, Fox SB, Generali D.

Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):887-92. doi: 10.1080/17474124.2016.1209407. Epub 2016 Jul 15. Review.

PMID:
27376400
9.

Evaluation of enzymatic and non-enzymatic antioxidants in seminal plasma of men with genitourinary infections, varicocele and idiopathic infertility.

Micheli L, Cerretani D, Collodel G, Menchiari A, Moltoni L, Fiaschi AI, Moretti E.

Andrology. 2016 May;4(3):456-64. doi: 10.1111/andr.12181. Epub 2016 Mar 29.

10.

Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Miano ST, Marrelli D, Roviello F, Bianco V, Francini E.

Future Oncol. 2015 Sep;11(18):2563-74. doi: 10.2217/fon.15.105. Epub 2015 Aug 28.

PMID:
26314701
11.

Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status.

Petrioli R, Francini E, Roviello F, Marrelli D, Miano ST, Fiaschi AI, Laera L, Bellini MA, Roviello G.

J Geriatr Oncol. 2015 Sep;6(5):380-6. doi: 10.1016/j.jgo.2015.06.002. Epub 2015 Jul 27.

PMID:
26228711
12.

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival.

Francini E, Fiaschi AI, Petrioli R, Bianco V, Laera L, Francini F, Roviello G.

Anticancer Drugs. 2015 Sep;26(8):910-1. doi: 10.1097/CAD.0000000000000258. No abstract available.

PMID:
26207428
13.

Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate.

Petrioli R, Francini E, Laera L, Fiaschi AI, Ponchietti R, Roviello G.

Cancer Chemother Pharmacol. 2015 Sep;76(3):439-45. doi: 10.1007/s00280-015-2803-y. Epub 2015 Jun 17. Review.

PMID:
26082421
14.

Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.

Francini E, Fiaschi AI, Petrioli R, Laera L, Bianco V, Ponchietti R, Roviello G.

Anticancer Drugs. 2015 Sep;26(8):884-7. doi: 10.1097/CAD.0000000000000257.

PMID:
26053281
15.

Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Miano ST, Bianco V, Francini E.

Anticancer Drugs. 2015 Sep;26(8):878-83. doi: 10.1097/CAD.0000000000000254.

PMID:
26053279
16.

Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer.

Petrioli R, Francini E, Fiaschi AI, Laera L, Miano ST, De Rubertis G, Roviello G.

Anticancer Res. 2015 May;35(5):3097-102.

PMID:
25964601
17.

Targeted Therapies for Prostate Cancer.

Petrioli R, Francini E, Fiaschi AI, Laera L, Roviello G.

Cancer Invest. 2015;33(7):276-85. doi: 10.3109/07357907.2015.1033105. Epub 2015 May 7. Review.

PMID:
25951372
18.

Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Bianco V, Ponchietti R, Barbanti G, Francini E.

Clin Genitourin Cancer. 2015 Oct;13(5):441-6. doi: 10.1016/j.clgc.2015.03.004. Epub 2015 Mar 26.

PMID:
25920994
19.

Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Roviello F, Marrelli D, Francini E.

Anticancer Drugs. 2015 Jul;26(6):682-6. doi: 10.1097/CAD.0000000000000233.

PMID:
25811963
20.

Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study.

Petrioli R, Francini E, Fiaschi AI, Laera L, Luzzi L, Paladini P, Ghiribelli C, Voltolini L, Bianco V, Roviello G.

Med Oncol. 2015 Apr;32(4):134. doi: 10.1007/s12032-015-0587-x. Epub 2015 Mar 22.

PMID:
25796503
21.

Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.

Petrioli R, Francini E, Roviello F, Marrelli D, Fiaschi AI, Laera L, Rossi G, Bianco V, Brozzetti S, Roviello G.

Cancer Chemother Pharmacol. 2015 May;75(5):941-7. doi: 10.1007/s00280-015-2715-x. Epub 2015 Mar 6.

PMID:
25743995
22.

Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Miano ST, De Rubertis G, Barbanti G, Bianco V, Brozzetti S, Francini E.

Med Oncol. 2015 Mar;32(3):52. doi: 10.1007/s12032-015-0485-2. Epub 2015 Jan 31.

PMID:
25636506
23.

Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Marrelli D, Roviello F, Francini E.

Cancer Chemother Pharmacol. 2015 Apr;75(4):683-90. doi: 10.1007/s00280-015-2683-1. Epub 2015 Jan 25.

PMID:
25618415
24.

Disentangling the Role of Cortico-Basal Ganglia Loops in Top-Down and Bottom-Up Visual Attention: An Investigation of Attention Deficits in Parkinson Disease.

Tommasi G, Fiorio M, Yelnik J, Krack P, Sala F, Schmitt E, Fraix V, Bertolasi L, Le Bas JF, Ricciardi GK, Fiaschi A, Theeuwes J, Pollak P, Chelazzi L.

J Cogn Neurosci. 2015 Jun;27(6):1215-37. doi: 10.1162/jocn_a_00770. Epub 2014 Dec 16.

PMID:
25514652
25.

Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancer.

Francini E, Petrioli R, Fiaschi AI, Laera L, Roviello G.

Medicine (Baltimore). 2014 Dec;93(27):e163. doi: 10.1097/MD.0000000000000163.

26.

Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma.

Francini E, Mazzaroppi S, Fiaschi AI, Petrioli R, Laera L, Roviello G, Pira T, Pellicelli AM, Bianco V.

J Am Geriatr Soc. 2014 Nov;62(11):2204-5. doi: 10.1111/jgs.13091. No abstract available.

PMID:
25413190
27.

Chronic nandrolone administration promotes oxidative stress, induction of pro-inflammatory cytokine and TNF-α mediated apoptosis in the kidneys of CD1 treated mice.

Riezzo I, Turillazzi E, Bello S, Cantatore S, Cerretani D, Di Paolo M, Fiaschi AI, Frati P, Neri M, Pedretti M, Fineschi V.

Toxicol Appl Pharmacol. 2014 Oct 1;280(1):97-106. doi: 10.1016/j.taap.2014.06.031. Epub 2014 Jul 25.

PMID:
25065671
28.

The cerebellum and visual perceptual learning: evidence from a motion extrapolation task.

Deluca C, Golzar A, Santandrea E, Lo Gerfo E, Eštočinová J, Moretto G, Fiaschi A, Panzeri M, Mariotti C, Tinazzi M, Chelazzi L.

Cortex. 2014 Sep;58:52-71. doi: 10.1016/j.cortex.2014.04.017. Epub 2014 Jun 2.

PMID:
24959702
29.

Investigation of brain hemodynamic changes induced by active and passive movements: a combined arterial spin labeling-BOLD fMRI study.

Boscolo Galazzo I, Storti SF, Formaggio E, Pizzini FB, Fiaschi A, Beltramello A, Bertoldo A, Manganotti P.

J Magn Reson Imaging. 2014 Oct;40(4):937-48. doi: 10.1002/jmri.24432. Epub 2013 Nov 4.

PMID:
24924449
30.

Time-frequency modulation of ERD and EEG coherence in robot-assisted hand performance.

Formaggio E, Storti SF, Boscolo Galazzo I, Gandolfi M, Geroin C, Smania N, Fiaschi A, Manganotti P.

Brain Topogr. 2015 Mar;28(2):352-63. doi: 10.1007/s10548-014-0372-8. Epub 2014 May 17.

PMID:
24838817
31.

Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis.

Piffer S, Turri G, Acler M, Richelli S, Cerini R, Fiaschi A, Monaco S, Bonetti B.

J Neurol Sci. 2014 Jun 15;341(1-2):85-7. doi: 10.1016/j.jns.2014.04.008. Epub 2014 Apr 13.

PMID:
24780438
32.

Spatial and Temporal EEG-fMRI Changes During Preictal and Postictal Phases in a Patient With Posttraumatic Epilepsy.

Storti SF, Del Felice A, Formaggio E, Boscolo Galazzo I, Bongiovanni LG, Cerini R, Fiaschi A, Manganotti P.

Clin EEG Neurosci. 2015 Jul;46(3):247-52. doi: 10.1177/1550059414523960. Epub 2014 Apr 17.

PMID:
24743547
33.

EEG-fMRI evaluation of patients with mesial temporal lobe sclerosis.

Avesani M, Giacopuzzi S, Bongiovanni LG, Borelli P, Cerini R, Pozzi Mucelli R, Fiaschi A.

Neuroradiol J. 2014 Feb;27(1):45-54. Epub 2014 Feb 24.

34.

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer.

Francini E, Fiaschi AI, Petrioli R, Francini F, Bianco V, Perrella A, Paganini G, Laera L, Roviello G.

Anticancer Drugs. 2014 Apr;25(4):472-7. doi: 10.1097/CAD.0000000000000072.

PMID:
24394473
35.

Time-frequency analysis of short-lasting modulation of EEG induced by TMS during wake, sleep deprivation and sleep.

Manganotti P, Formaggio E, Del Felice A, Storti SF, Zamboni A, Bertoldo A, Fiaschi A, Toffolo GM.

Front Hum Neurosci. 2013 Nov 18;7:767. doi: 10.3389/fnhum.2013.00767. eCollection 2013.

36.

Electrical source imaging of sleep spindles.

Del Felice A, Arcaro C, Storti SF, Fiaschi A, Manganotti P.

Clin EEG Neurosci. 2014 Jul;45(3):184-92.

PMID:
24114073
37.

Reproducibility of EEG-fMRI results in a patient with fixation-off sensitivity.

Formaggio E, Storti SF, Galazzo IB, Bongiovanni LG, Cerini R, Fiaschi A, Manganotti P.

Clin EEG Neurosci. 2014 Jul;45(3):212-7.

PMID:
24048241
38.

Effect of voluntary repetitive long-lasting muscle contraction activity on the BOLD signal as assessed by optimal hemodynamic response function.

Storti SF, Formaggio E, Moretto D, Bertoldo A, Pizzini FB, Beltramello A, Fiaschi A, Toffolo GM, Manganotti P.

MAGMA. 2014 Apr;27(2):171-84. doi: 10.1007/s10334-013-0401-8. Epub 2013 Sep 3.

PMID:
23999996
39.

Effect of high-frequency repetitive transcranial magnetic stimulation on brain excitability in severely brain-injured patients in minimally conscious or vegetative state.

Manganotti P, Formaggio E, Storti SF, Fiaschi A, Battistin L, Tonin P, Piccione F, Cavinato M.

Brain Stimul. 2013 Nov;6(6):913-21. doi: 10.1016/j.brs.2013.06.006. Epub 2013 Jul 25.

PMID:
23928101
40.

Slow spindles' cortical generators overlap with the epileptogenic zone in temporal epileptic patients: an electrical source imaging study.

Del Felice A, Arcaro C, Storti SF, Fiaschi A, Manganotti P.

Clin Neurophysiol. 2013 Dec;124(12):2336-44. doi: 10.1016/j.clinph.2013.06.002. Epub 2013 Jul 10.

PMID:
23849700
41.

Modelling hemodynamic response function in epilepsy.

Storti SF, Formaggio E, Bertoldo A, Manganotti P, Fiaschi A, Toffolo GM.

Clin Neurophysiol. 2013 Nov;124(11):2108-18. doi: 10.1016/j.clinph.2013.05.024. Epub 2013 Jul 9.

PMID:
23845895
42.

Automatic selection of resting-state networks with functional magnetic resonance imaging.

Storti SF, Formaggio E, Nordio R, Manganotti P, Fiaschi A, Bertoldo A, Toffolo GM.

Front Neurosci. 2013 May 20;7:72. doi: 10.3389/fnins.2013.00072. eCollection 2013.

43.

Visual cortex hyperexcitability in idiopathic generalized epilepsies with photosensitivity: a TMS pilot study.

Brigo F, Bongiovanni LG, Nardone R, Trinka E, Tezzon F, Fiaschi A, Manganotti P.

Epilepsy Behav. 2013 May;27(2):301-6. doi: 10.1016/j.yebeh.2013.02.010. Epub 2013 Mar 18.

PMID:
23518608
44.

Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation.

Formaggio E, Storti SF, Tramontano V, Casarin A, Bertoldo A, Fiaschi A, Talacchi A, Sala F, Toffolo GM, Manganotti P.

Front Neuroeng. 2013 Feb 25;6:1. doi: 10.3389/fneng.2013.00001. eCollection 2013.

45.

Modulation of event-related desynchronization in robot-assisted hand performance: brain oscillatory changes in active, passive and imagined movements.

Formaggio E, Storti SF, Boscolo Galazzo I, Gandolfi M, Geroin C, Smania N, Spezia L, Waldner A, Fiaschi A, Manganotti P.

J Neuroeng Rehabil. 2013 Feb 26;10:24. doi: 10.1186/1743-0003-10-24.

46.

Head drop in progressive supranuclear palsy: an unusual association with amyotrophic lateral sclerosis.

Brigo F, Bovi T, Ferigo L, Musso A, Gambina G, Tinazzi M, Moretto G, Fiaschi A, Squintani G.

Parkinsonism Relat Disord. 2013 Apr;19(4):467-8. doi: 10.1016/j.parkreldis.2012.10.002. Epub 2012 Oct 24. No abstract available.

PMID:
23102427
47.

Tongue biting in epileptic seizures and psychogenic events: an evidence-based perspective.

Brigo F, Storti M, Lochner P, Tezzon F, Fiaschi A, Bongiovanni LG, Nardone R.

Epilepsy Behav. 2012 Oct;25(2):251-5. doi: 10.1016/j.yebeh.2012.06.020. Epub 2012 Oct 2. Review.

PMID:
23041172
48.

Fixation-off sensitivity.

Brigo F, Rossini F, Stefani A, Nardone R, Tezzon F, Fiaschi A, Manganotti P, Bongiovanni LG.

Clin Neurophysiol. 2013 Feb;124(2):221-7. doi: 10.1016/j.clinph.2012.07.017. Epub 2012 Aug 24. Review.

PMID:
22925838
49.

Atypical presentation of thalamic post-stroke pain.

Brigo F, Rossini F, Stefani A, Tocco P, Fiaschi A, Salviati A.

Neurol Sci. 2013 Jun;34(6):1015-7. doi: 10.1007/s10072-012-1162-2. Epub 2012 Jul 25. No abstract available.

PMID:
22829133
50.

Reduced-intensity modified constraint-induced movement therapy versus conventional therapy for upper extremity rehabilitation after stroke: a multicenter trial.

Smania N, Gandolfi M, Paolucci S, Iosa M, Ianes P, Recchia S, Giovanzana C, Molteni F, Avesani R, Di Paolo P, Zaccala M, Agostini M, Tassorelli C, Fiaschi A, Primon D, Ceravolo MG, Farina S.

Neurorehabil Neural Repair. 2012 Nov-Dec;26(9):1035-45. doi: 10.1177/1545968312446003. Epub 2012 Jun 1.

PMID:
22661278

Supplemental Content

Loading ...
Support Center